Denali Advisors LLC

SEC CIK: 0001142941
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

PRLD holding history

Prelude Therapeutics Inc in every 13F filed by Denali Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRLD overview All 13F holders of PRLD Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2022

Holdings of PRLD by Denali Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−8,200−100.0%	Sold out	Holders
Q1 2023	8,200	$46.7K	<0.1%	00.0%	Unchanged	Holders
Q4 2022	8,200	$49.5K	<0.1%	00.0%	Unchanged	Holders
Q3 2022	8,200	$54.0K	<0.1%	+8,200	New	Holders